] Intravenous doses of a synthetic component of "good"
] cholesterol reduced artery disease in just six weeks in a
] small study with startlingly big implications for
] treating the nation's No. 1 killer.
]
] "The concept is sort of liquid Drano for the coronary
] arteries," said Dr. Steven Nissen, a Cleveland Clinic
] cardiologist who led the study.
]
] Larger and longer studies need to be done to determine if
] the experimental treatment will translate into fewer
] deaths, but the early results are promising, said Dr.
] Daniel Rader, director of preventive cardiology at the
] University of Pennsylvania School of Medicine.
]
] The treatment used a laboratory-produced version of an
] unusually effective form of HDL, the good cholesterol
] that helps protect against heart disease by removing
] plaque, or fatty buildups, from the bloodstream.
]
] "This is clearly on the level of a breakthrough that will
] have far-reaching implications," pointing the way toward
] a rapid treatment for fatty buildups, said Dr. Bryan
] Brewer, chief of molecular diseases at the National
] Heart, Lung and Blood Institute.

Kick ass!

] Intravenous doses of a synthetic component of "good"
] cholesterol reduced artery disease in just six weeks in a
] small study with startlingly big implications for
] treating the nation's No. 1 killer.
]
] "The concept is sort of liquid Drano for the coronary
] arteries," said Dr. Steven Nissen, a Cleveland Clinic
] cardiologist who led the study.
]
] Larger and longer studies need to be done to determine if
] the experimental treatment will translate into fewer
] deaths, but the early results are promising, said Dr.
] Daniel Rader, director of preventive cardiology at the
] University of Pennsylvania School of Medicine.
]
] The treatment used a laboratory-produced version of an
] unusually effective form of HDL, the good cholesterol
] that helps protect against heart disease by removing
] plaque, or fatty buildups, from the bloodstream.
]
] "This is clearly on the level of a breakthrough that will
] have far-reaching implications," pointing the way toward
] a rapid treatment for fatty buildups, said Dr. Bryan
] Brewer, chief of molecular diseases at the National
] Heart, Lung and Blood Institute.

] Intravenous doses of a synthetic component of "good"
] cholesterol reduced artery disease in just six weeks in a
] small study with startlingly big implications for
] treating the nation's No. 1 killer.
]
] "The concept is sort of liquid Drano for the coronary
] arteries," said Dr. Steven Nissen, a Cleveland Clinic
] cardiologist who led the study.
]
] Larger and longer studies need to be done to determine if
] the experimental treatment will translate into fewer
] deaths, but the early results are promising, said Dr.
] Daniel Rader, director of preventive cardiology at the
] University of Pennsylvania School of Medicine.
]
] The treatment used a laboratory-produced version of an
] unusually effective form of HDL, the good cholesterol
] that helps protect against heart disease by removing
] plaque, or fatty buildups, from the bloodstream.
]
] "This is clearly on the level of a breakthrough that will
] have far-reaching implications," pointing the way toward
] a rapid treatment for fatty buildups, said Dr. Bryan
] Brewer, chief of molecular diseases at the National
] Heart, Lung and Blood Institute.

Kick ass!

[Science is soooooo rad sometimes. Now, who wants to go grab some burgers and fries?;) - Nano]